Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from ...
While few official interviews for the Baltimore Orioles’ managerial job have been reported so far, other teams with openings continue to speak with their former ...
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose ...
Incumbent Peter Brown and challengers Julie Lumpkin and Ashley McCall outline their priorities for Columbia’s District 4 ...
Q3 2025 Earnings Call Transcript October 24, 2025 Gentex Corporation misses on earnings expectations. Reported EPS is $0.46 ...
Q3 2025 Earnings Call Transcript October 23, 2025SS&C Technologies Holdings, Inc. beats earnings expectations.
In August 2025, a total of 52 tankers exported CPC oil from the Russian port of Novorossiysk, excluding the exports to ...
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback